Medical and Pharmaceutical Trevi Therapeutics jumps 20% on study linking GLP-1 drugs to Chronic Cough Investors reacted to a study suggesting the receptor used in drugs like Ozempic and Wegovy may raise the risk of chronic cough Joseph Morton12 hours ago